Ureteroscopic management of renal calculi in anomalous kidneys.

Sky is no limit for ureteroscopy: extending the indications and special circumstances. World J Urol (2014) 1.01

Clinical effectiveness of the PolyScope™ endoscope system combined with holmium laser lithotripsy in the treatment of upper urinary calculi with a diameter of less than 2 cm. Exp Ther Med (2013) 0.89

Outcome of ureteroscopy for stone disease in patients with horseshoe kidney: Review of world literature. Urol Ann (2015) 0.88

Flexible Ureteroscopic Management of Horseshoe Kidney Renal Calculi. Int Braz J Urol (2015) 0.87

Outcomes of retrograde flexible ureteroscopy and laser lithotripsy for stone disease in patients with anomalous kidneys. Urolithiasis (2014) 0.84

Initial experiences with laparoscopy and flexible ureteroscopy combination pyeloplasty in management of ectopic pelvic kidney with stone and ureter-pelvic junction obstruction. Urolithiasis (2015) 0.83

Stones in special situations. World J Urol (2017) 0.83

FlexGuard: a new laser insertion sheath: functional aspects in ureterorenoscopy (URS). World J Urol (2007) 0.80

'Mini, ultra, micro' - nomenclature and cost of these new minimally invasive percutaneous nephrolithotomy (PCNL) techniques. Ther Adv Urol (2015) 0.79

The role of open and laparoscopic stone surgery in the modern era of endourology. Nat Rev Urol (2015) 0.78

Treatment of calculi in kidneys with congenital anomalies: an assessment of the efficacy of lithotripsy. Urol Res (2006) 0.77

Outcome of percutaneous nephrolithotomy in anomalous kidney: Is it different? Urol Ann (2017) 0.75

Comparison of shock wave lithotripsy (SWL) and retrograde intrarenal surgery (RIRS) for treatment of stone disease in horseshoe kidney patients. Int Braz J Urol (2016) 0.75

Role of flexible uretero-renoscopy in management of renal calculi in anomalous kidneys: single-center experience. World J Urol (2016) 0.75

Laparoscopy assisted percutaneous stone surgery can be performed in multiple ways for pelvic ectopic kidneys. Urolithiasis (2015) 0.75

Chapter 1: AUA guideline on management of staghorn calculi: diagnosis and treatment recommendations. J Urol (2005) 4.69

2007 guideline for the management of ureteral calculi. J Urol (2007) 4.44

2007 Guideline for the management of ureteral calculi. Eur Urol (2007) 3.98

Kidney stones: a global picture of prevalence, incidence, and associated risk factors. Rev Urol (2010) 3.62

The effect of shock wave rate on the outcome of shock wave lithotripsy: a meta-analysis. J Urol (2007) 2.78

Prospective randomized trial comparing shock wave lithotripsy and ureteroscopy for lower pole caliceal calculi 1 cm or less. J Urol (2008) 2.40

Prospective, randomized trial comparing shock wave lithotripsy and ureteroscopy for lower pole caliceal calculi 1 cm or less. J Urol (2005) 2.31

Changing gender prevalence of stone disease. J Urol (2007) 2.25

A novel drug eluting ureteral stent: a prospective, randomized, multicenter clinical trial to evaluate the safety and effectiveness of a ketorolac loaded ureteral stent. J Urol (2010) 2.21

Clinical outcomes after ureteroscopic lithotripsy in patients who initially presented with urosepsis: matched pair comparison with elective ureteroscopy. J Endourol (2014) 2.17

A critical assessment of the quality of reporting of randomized, controlled trials in the urology literature. J Urol (2007) 2.16

Beyond prone position in percutaneous nephrolithotomy: a comprehensive review. Eur Urol (2008) 2.05

Percutaneous management of calculi within horseshoe kidneys. J Urol (2003) 2.04

Clinical effectiveness protocols for imaging in the management of ureteral calculous disease: AUA technology assessment. J Urol (2012) 1.94

The association of increasing body mass index and kidney stone disease. J Urol (2009) 1.94

The role of stress waves and cavitation in stone comminution in shock wave lithotripsy. Ultrasound Med Biol (2002) 1.92

Renal stone assessment with dual-energy multidetector CT and advanced postprocessing techniques: improved characterization of renal stone composition--pilot study. Radiology (2009) 1.90

Pain after percutaneous nephrolithotomy: impact of nephrostomy tube size. J Endourol (2003) 1.83

Oxalobacter formigenes may reduce the risk of calcium oxalate kidney stones. J Am Soc Nephrol (2008) 1.82

Dietary oxalate loads and renal oxalate handling. J Urol (2005) 1.81

Sex prevalence of pediatric kidney stone disease in the United States: an epidemiologic investigation. Urology (2009) 1.74

Validity of administrative coding in identifying patients with upper urinary tract calculi. J Urol (2010) 1.72

A formal test of the hypothesis that idiopathic calcium oxalate stones grow on Randall's plaque. BJU Int (2008) 1.72

Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients. J Urol (2004) 1.70

Metabolic abnormalities associated with renal calculi in patients with horseshoe kidneys. J Endourol (2004) 1.65

Determining the incidence of horseshoe kidney from radiographic data at a single institution. J Urol (2003) 1.64

Ureteral access sheath provides protection against elevated renal pressures during routine flexible ureteroscopic stone manipulation. J Endourol (2004) 1.63

Reduced radiation exposure with the use of an air retrograde pyelogram during fluoroscopic access for percutaneous nephrolithotomy. J Endourol (2011) 1.61

The impact of dietary calcium and oxalate ratios on stone risk. Urology (2012) 1.60

Treatment efficacy and outcomes using a third generation shockwave lithotripter. BJU Int (2013) 1.57

Percutaneous CT-guided radiofrequency ablation of renal neoplasms: factors influencing success. AJR Am J Roentgenol (2004) 1.56

The effect of gastric banding on kidney stone disease. Urology (2009) 1.56

Radiation exposure in the acute and short-term management of urolithiasis at 2 academic centers. J Urol (2008) 1.53

Determination of patient radiation dose during ureteroscopic treatment of urolithiasis using a validated model. J Urol (2012) 1.51

Biochemical profile of stone-forming patients with diabetes mellitus. Urology (2003) 1.51

Medical comorbidities associated with pediatric kidney stone disease. Urology (2010) 1.50

Techniques for fluoroscopic percutaneous renal access. J Urol (2007) 1.50

Differentiation of kidney stones using dual-energy CT with and without a tin filter. AJR Am J Roentgenol (2012) 1.49

Evaluating the evidence: statistical methods in randomized controlled trials in the urological literature. J Urol (2008) 1.48

Long-term combined treatment with thiazide and potassium citrate in nephrolithiasis does not lead to hypokalemia or hypochloremic metabolic alkalosis. Kidney Int (2003) 1.46

Third prize: the role of endoscopic nephron-sparing surgery in the management of upper tract urothelial carcinoma. J Endourol (2011) 1.45

The effect of dietary sodium and fructose intake on urine and serum parameters of stone formation in a pediatric mouse model: a pilot study. J Urol (2013) 1.44

Defining hypercalciuria in nephrolithiasis. Kidney Int (2011) 1.44

Trends in renal surgery: robotic technology is associated with increased use of partial nephrectomy. J Urol (2012) 1.42

Re: Randomized and double-blinded clinical trial of the safety and calcium kidney stone dissolving efficacy of Lapis judaicus. J Urol (2014) 1.38

Glycolate and glyoxylate metabolism in HepG2 cells. Am J Physiol Cell Physiol (2004) 1.38

Innovations in shock wave lithotripsy technology: updates in experimental studies. J Urol (2004) 1.36

Changing indications of open stone surgery. Urology (2002) 1.34

Surgical simulation: a urological perspective. J Urol (2008) 1.34

Shock wave lithotripsy or ureteroscopy for the management of proximal ureteral calculi: an old discussion revisited. J Urol (2007) 1.32

The impact of dietary oxalate on kidney stone formation. Urol Res (2004) 1.30

Simultaneous combined use of flexible ureteroscopy and percutaneous nephrolithotomy to reduce the number of access tracts in the management of complex renal calculi. BJU Int (2005) 1.30

The effect of treatment strategy on stone comminution efficiency in shock wave lithotripsy. J Urol (2004) 1.29

Sensitivity of human strains of Oxalobacter formigenes to commonly prescribed antibiotics. Urology (2012) 1.29

Subcutaneous bupivacaine infiltration and postoperative pain perception after percutaneous nephrolithotomy. J Urol (2007) 1.24

Uric Acid nephrolithiasis: recent progress and future directions. Rev Urol (2007) 1.23

Local cost structures and the economics of robot assisted radical prostatectomy. J Urol (2005) 1.23

How to use a systematic literature review and meta-analysis. J Urol (2008) 1.23

Internet based multi-institutional clinical research: a convenient and secure option. J Urol (2004) 1.23

Effect of ureteral access sheath on stone-free rates in patients undergoing ureteroscopic management of renal calculi. Urology (2005) 1.22

Management of nephropleural fistula after supracostal percutaneous nephrolithotomy. Urology (2004) 1.22

Prevalence of hyperoxaluria after bariatric surgery. J Urol (2008) 1.22

Impact of dietary calcium and oxalate, and Oxalobacter formigenes colonization on urinary oxalate excretion. J Urol (2011) 1.16

Practice variation in the surgical management of urinary lithiasis. J Urol (2011) 1.16

Evidence based clinical practice: a primer for urologists. J Urol (2007) 1.13

Routine ureteral stenting is not necessary after ureteroscopy and ureteropyeloscopy: a randomized trial. J Endourol (2002) 1.13

Computerized tomography guided access for percutaneous nephrostolithotomy. J Urol (2003) 1.12

Laser Doppler flowmetric determination of ureteral blood flow after ureteral access sheath placement. J Endourol (2002) 1.12

Hand assisted laparoscopic training for postgraduate urologists: the role of mentoring. J Urol (2004) 1.11

Accuracy of urinary dipstick testing for pH manipulation therapy. J Endourol (2008) 1.10

How do we manage infected, obstructed hydronephrosis? Eur Urol (2012) 1.10

Hypocitraturia: pathophysiology and medical management. Rev Urol (2009) 1.10

Disposable devices for RIRS: where do we stand in 2013? What do we need in the future? World J Urol (2014) 1.09

Increased protein intake on controlled oxalate diets does not increase urinary oxalate excretion. Urol Res (2009) 1.09

Holmium laser for stone management. World J Urol (2007) 1.09

Metabolic syndrome and urologic diseases. Rev Urol (2010) 1.09

Acute effects of percutaneous tract dilation on renal function and structure. J Endourol (2006) 1.09

The genetic composition of Oxalobacter formigenes and its relationship to colonization and calcium oxalate stone disease. Urolithiasis (2013) 1.08

Progressive increase of lithotripter output produces better in-vivo stone comminution. J Endourol (2006) 1.08

In vitro assessment of a novel dual probe ultrasonic intracorporeal lithotriptor. J Urol (2007) 1.07

Safety and efficacy of holmium: YAG laser lithotripsy in patients with bleeding diatheses. J Urol (2002) 1.07

Prostate abscess following intravesical bacillus Calmette-Guerin treatment. J Urol (2002) 1.06

Effect of medical management on recurrent stone formation following percutaneous nephrolithotomy. J Urol (2007) 1.06

Assessing the impact of ureteral stent design on patient comfort. J Urol (2009) 1.06

High definition laparoscopy: objective assessment of performance characteristics and comparison with standard laparoscopy. J Endourol (2009) 1.06

Assessment of stricture formation with the ureteral access sheath. Urology (2003) 1.05

Trends in imaging use during the emergency department evaluation of flank pain. J Urol (2011) 1.05

Renal functional effects of multiple-tract percutaneous access. J Endourol (2009) 1.04

Holmium laser enucleation of the prostate for men with urinary retention. J Urol (2005) 1.04